Freezing of gait in older people: Associated conditions, clinical aspects, assessment and treatment

Postgraduate Medical Journal

Volumn 86, Issue 1018, 2010, Pages 472-477

  Thanvi, Bhomraj ^a   Treadwell, Sean D ^b  

^a SOUTH WARWICKSHIRE NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ATOMOXETINE; BOTULINUM TOXIN; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; RASAGILINE; SELEGILINE;

CLINICAL TRIAL; COGNITIVE DEFECT; FALLING; FREEZING OF GAIT; GAIT DISORDER; HUMAN; NEUROIMAGING; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; RISK FACTOR;

AGED; DOPAMINE AGENTS; GAIT DISORDERS, NEUROLOGIC; HUMANS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PATIENT CARE TEAM;

EID: 77956015636     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.090456     Document Type: Review

References (54)

1. Giladi N, McMahon D, Przedborski S, et al. Motor blocks in Parkinson's disease. Neurology 1992;42:333-9.
2. Giladi N, Nieuwboer A. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord 2008;23(Suppl 2): S423-5.
3. Macht M, Kaussner Y, Moller JC, et al. Predictors of freezing in Parkinson's disease: a survey of 6,620 patients. Mov Disord 2007;22:953-6. (Pubitemid 46999290)
4. Lamberti P, Armenise S, Castaldo V, et al. Freezing gait in Parkinson's disease. Eur Neurol 1997;38:297-301.
5. Bartels AL, Balash Y, Gurevich T, et al. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. J Clin Neurosci 2003;10:584-8. (Pubitemid 37138576)
6. Bloem BR, Hausdorff JM, Visser JE, et al. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord 2004;19:871-84.
7. Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 1997;12:302-5. (Pubitemid 27216127)
8. Müller J, Seppi K, Stefanova N, et al. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord 2002;17:1041-5.
9. Thanvi B, Lo N, Robinson T. Vascular parkinsonism - an important cause of parkinsonism in older people. Age Ageing 2005;34:114-19. (Pubitemid 40331090)
10. Thompson PD, Marsden CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease. Mov Disord 1987;2:1-8.
11. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102.
12. Gurevich T, Giladi N. Freezing of gait in multiple system atrophy (MSA). Parkinsonism Relat Disord 2003;9:169-74. (Pubitemid 36173567)
13. Williams DR, Holton JL, Strand K, et al. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007;22:2235-41.
14. Taniwaki T, Hosokawa S, Goto I, et al. Positron emission tomography (PET) in "pure akinesia". J Neurol Sci 1992;107:34-9.
15. Pramstaller PP, Salerno A, Bhatia KP, et al. Primary central nervous system lymphoma presenting with a parkinsonian syndrome of pure akinesia. J Neurol 1999;246:934-8. (Pubitemid 29512164)
16. Katayama S, Watanabe C, Khoriyama T, et al. Slowly progressive L-DOPA nonresponsive pure akinesia due to nigropallidal.degeneration: a clinicopathological case study. J Neurol Sci 1998;161:169-72. (Pubitemid 28559171)
17. Factor SA, Jennings DL, Molho ES, et al. The natural history of the syndrome of primary progressive freezing gait. Arch Neurol 2002;59:1778-83.
18. Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology 2006;66:411-14. (Pubitemid 43739946)
19. Stewart A, Factor S. The clinical spectrum of freezing of gait in atypical Parkinsonism. Mov Disord 2008;23(Suppl 2):S431-8.
20. Nieuwboer A, Rochester L, Herman T, et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. Gait Posture 2009;30:459-63.
21. Moore O, Peretz C, Giladi N. Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait. Mov Disord 2007;22:2192-5.
22. Snijders AH, Nijkrake MJ, Bakker M, et al. Clinimetrics of freezing of gait. Mov Disord 2008;23(Suppl 2):S468-74.
23. Moore ST, MacDougall HG, Ondo WG. Ambulatory monitoring of freezing of gait in Parkinson's disease. J Neurosci Methods 2008;167:340-8.
24. Shrivastava A. The hot cross bun sign. Radiology 2007;245:606-7.
25. Eidelberg D, Dhawan V. Can imaging distinguish PSP from other neurodegenerative disorders? Neurology 2002;58:997-8.
26. Bartels AL, Leenders KL. Brain imaging in patients with freezing of gait. Mov Disord 2008;23(Suppl 2):S461-7.
27. Lee MS, Kim HS, Lyoo CH. "Off" gait freezing and temporal discrimination threshold in patients with Parkinson disease. Neurology 2005;64:670-4.
28. Schaafsma JD, Balash Y, Gurevich T, et al. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 2003;10:391-8.
29. Parkinson Study Group. Does levodopa slow or hasten the rate of progression of Parkinson disease? The results of the ELLDOPA trial. Neurology 2003;60(suppl 1): A80-1.
30. Rascol O, Brooks DJ, Korczyn AD, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med 2000;342:1484-91. (Pubitemid 30318272)
31. Parkinson Study Group. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 2002;287:1653-61.
32. Giladi N, McDermott MP, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001;56:1712-21. (Pubitemid 32574572)
33. Shoulson I, Oakes D, Fahn S, et al. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Ann Neurol 2002;51:604-12.
34. Zúñiga C, Lester J, Cersósimo MG, et al. Treatment of primary progressive freezing of gait with high doses of selegiline. Clin Neuropharmacol 2006;29:20-1.
35. Giladi N, Rascol O, Brooks DJ, et al. Rasagiline treatment can improve freezing of gait in advanced Parkinson's disease: a prospective randomized, double blind, placebo and entacapone controlled study [abstract]. Neurology 2004;62(Suppl 5):A329.
36. Narabayashi H, Kondo T, Yokochi F, et al. Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia. Adv Neurol 1987;45:593-602.
37. Quinn N, Perlmutter J, Marsden CD. Acute administration of L-Threo-DOPS does not affect the freezing phenomenon in parkinsonian patients. Neurology 1984;34:149.
38. Jankovic J. Atomoxetine for freezing of gait in Parkinson disease. J Neurol Sci Published Online First: 8 April 2009.
39. Giladi N, Gurevich T, Shabtai H, et al. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 2001;248:572-6.
40. Wieler M, Camicioli R, Jones CA, et al. Botulinum toxin injections do not improve freezing of gait in Parkinson disease. Neurology 2005;65:626-8. (Pubitemid 41170731)
41. Fernandez HH, Lannon MC, Trieschmann ME, et al. Botulinum toxin type B for gait freezing in Parkinson's disease. Med Sci Monit 2004;10:CR282-4.
42. Pollak L, Dobronevsky Y, Prohorov T, et al. Low dose methylphenidate improves freezing in advanced Parkinson's disease during off-state. J Neural Transm Suppl 2007;(72):145-8.
43. Nutt JG, Carter JH, Carlson NE. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial. Arch Neurol 2007;64:319-23.
44. Devos D, Krystkowiak P, Clement F, et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:470-5.
45. Martin JP. The basal ganglia and posture. Philadelphia: JB Lippincott, 1967. P24-38.
46. Cubo E, Moore CG, Leurgans S, et al. Wheeled and standard walkers in Parkinson's disease patients with gait freezing. Parkinsonism Relat Disord 2003; 10:9-14. (Pubitemid 37117385)
47. Dibble LE, Nicholson DE, Shultz B, et al. Sensory cueing effects on maximal speed gait initiation in persons with Parkinson's disease and healthy elders. Gait Posture 2004;19:215-25. (Pubitemid 38569884)
48. Dietz MA, Goetz CG, Stebbins GT. Evaluation of a modified inverted walking stick as a treatment for parkinsonian freezing episodes. Mov Disord 1990;5:243-7.
49. Nieuwboer A, Kwakkel G, Rochester I, et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 2007;78:134-40. (Pubitemid 46220208)
50. Frazzitta G, Maestri R, Uccellini D, et al. Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: a comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training. Mov Disord 2009;24:1139-43.
51. Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease. Clin Trials. gov identifier: NCT00819949.
52. Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues. Brain 2000;123:2077-90.
53. Ferraye MU, Debû B, Fraix V, et al. Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease. Neurology 2008;70:1431-7.
54. Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007; 130:1596-607. (Pubitemid 47355911)